Treatment with R-bendamustine followed by Y-90 ibritumomab tiuxetan for relapsed/refractory low-grade B-cell lymphoma

被引：0
|
作者：
Nikkuni, Koji [1 ]
Abe, Takashi [1 ]
Takai, Kazue [1 ]
机构：
[1] Niigata City Gen Hosp, Niigata, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-13-5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma
    Motomura, Sayuri
    Suda, Atsuhiro
    Inoue, Misato
    Takashi, Yoshikawa
    Atsushi, Yamamoto
    Hiroko, Hidai
    Hisashi, Tsutsumi
    Junichi, Nagashima
    ANNALS OF ONCOLOGY, 2015, 26 : 109 - 109
  • [2] BENDAMUSTINE WITH RITUXIMAB FOR RELAPSED OR REFRACTORY LOW-GRADE B-CELL LYMPHOMA
    Oda, H.
    Ikeda, M.
    Choi, I.
    Suehiro, Y.
    Abe, Y.
    Uike, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 106 - 106
  • [3] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [4] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
    Olivas, C.
    Bello, P.
    Vercher, J. L.
    Loaiza, J. L.
    Marti, J. F.
    Hervas, I.
    Rivas, A.
    Ruiz, C.
    Perez-Velasco, R.
    Mateo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [5] Assessment of Metabolic Response to Radioimmunotherapy (RIT) with Yttrium-90 (Y-90) Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-cell non-Hodgkin Lymphoma
    Storto, G.
    Nardelli, A.
    Pellegrino, T.
    Perna, F.
    De Falco, T.
    Erra, P.
    Ortosecco, G.
    Castaldi, E.
    Speranza, A.
    Klain, M.
    De Renzo, A.
    di Nuzzo, C.
    Pace, L.
    Rotoli, B.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S148 - S148
  • [6] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Palumbo, B.
    Sabalich, I.
    Falcinelli, F.
    Capponi, M.
    Martelli, M.
    Palumbo, R.
    Sinzinger, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [7] Assessment of 111In-Ibritumomab pretreatment imaging in 90Y-Ibritumomab radioimmunotherapy for relapsed or refractory low-grade B cell lymphoma.
    Kaneko, K.
    Uike, N.
    Shinozaki, K.
    Choi, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S372 - S372
  • [8] Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
    Tobinai, Kensei
    Watanabe, Takashi
    Ogura, Michinori
    Morishima, Yasuo
    Hotta, Tomomitsu
    Ishizawa, Kenichi
    Itoh, Kuniaki
    Okamoto, Shin-ichiro
    Taniwaki, Masafumi
    Tsukamoto, Norifumi
    Okumura, Hirokazu
    Terauchi, Takashi
    Nawano, Shigeru
    Matsusako, Masaki
    Matsuno, Yoshihiro
    Nakamura, Shigeo
    Mori, Shigeo
    Ohashi, Yasuo
    Hayashi, Masaki
    Endo, Keigo
    CANCER SCIENCE, 2009, 100 (01) : 158 - 164
  • [9] RADIOIMMUNOTHERAPY OF (90Y)-IBRITUMOMAB TIUXETAN FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
    Yoshida, Isao
    Kogure, Yuuki
    Kajihara, Makoto
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] BENDAMUSTINE THERAPY FOR RELAPSED OR REFRACTORY LOW GRADE B-CELL LYMPHOMA AND MANTLE CELL LYMPHOMA
    Yamada, T.
    Tsurumi, H.
    Kitagawa, J.
    Kanemura, N.
    Goto, N.
    Kasahara, S.
    Goto, H.
    Fukuno, K.
    Sawada, M.
    Moriwaki, H.
    ANNALS OF ONCOLOGY, 2013, 24 : 54 - 54
12345